Swiss Federal Institute of Technology in Zurich-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2017

  1. Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule Are Induced by Ionizing Radiation on Lymphatic Endothelium

    International Journal of Radiation Oncology Biology Physics, Vol. 97, Núm. 2, pp. 389-400

  2. T Cell Migration from Inflamed Skin to Draining Lymph Nodes Requires Intralymphatic Crawling Supported by ICAM-1/LFA-1 Interactions

    Cell Reports, Vol. 18, Núm. 4, pp. 857-865

2015

  1. Erratum to: GespeR: A statistical model for deconvoluting off-target-confounded RNA interference screens [Genome Biol. (2015) 16:220]

    Genome Biology

  2. gespeR: A statistical model for deconvoluting off-target-confounded RNA interference screens

    Genome Biology, Vol. 16, Núm. 1

2014

  1. Simultaneous analysis of large-scale RNAi screens for pathogen entry

    BMC Genomics, Vol. 15, Núm. 1

  2. Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 12, pp. 4548-4553

2005

  1. Gentamicin loaded microspheres for treatment of experimental Brucella abortus infection in mice

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 6, pp. 1032-1036

2004

  1. Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes

    Journal of Antimicrobial Chemotherapy, Vol. 53, Núm. 6, pp. 981-988

  2. New therapeutic approaches for the treatment of Brucella infections: Gentamicin entrapment into drug delivery systems

    Current Medicinal Chemistry: Anti-Infective Agents, Vol. 3, Núm. 1, pp. 43-56

2002

  1. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres

    European Journal of Pharmaceutical Sciences, Vol. 15, Núm. 2, pp. 197-207

2000

  1. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections

    International Journal of Pharmaceutics, Vol. 196, Núm. 1, pp. 115-125